Verition Fund Management LLC Gilead Sciences, Inc. Transaction History

Verition Fund Management LLC

$17.4 Billion
Q3 2024

A detailed history of Verition Fund Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 53,800 shares of GILD stock, worth $4.91 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

53,800

Previous 45,400 18.5%

Holding current value

$4.91 Million

Previous $3.11 Million 44.8%

% of portfolio

0.03%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $4.02 Million - $5.07 Million	-60,372 Reduced 59.47%	41,146 $3.45 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $2.15 Million - $2.49 Million	34,101 Added 50.58%	101,518 $6.97 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $1.45 Million - $1.77 Million	20,225 Added 42.86%	67,417 $4.94 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $663,972 - $752,961	9,062 Added 23.77%	47,192 $3.82 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $2.82 Million - $3.08 Million	38,130 New	38,130 $2.86 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $2.33 Million - $3.35 Million	-37,413 Reduced 77.91%	10,608 $910,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $1.14 Million - $1.3 Million	19,171 Added 66.45%	48,021 $2.96 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $1.17 Million - $1.32 Million	-20,292 Reduced 41.29%	28,850 $1.78 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $1.46 Million - $1.83 Million	25,149 Added 104.82%	49,142 $2.92 Million
Q4 2021 May 03, 2022	SELL	$64.88 - $73.64 $2.48 Million - $2.81 Million	-38,200 Reduced 61.42%	23,993 $1.74 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $4.04 Million - $4.58 Million	62,193 New	62,193 $4.52 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $7.78 Million - $8.5 Million	-122,516 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$60.0 - $68.46 $6.94 Million - $7.91 Million	115,611 Added 1674.31%	122,516 $7.92 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $391,168 - $445,717	6,905 New	6,905 $402,000
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $3 Million - $3.77 Million	-48,277 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $875,603 - $1.02 Million	-12,104 Reduced 20.05%	48,277 $3.71 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $1.07 Million - $1.18 Million	17,399 Added 40.48%	60,381 $3.92 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $1.85 Million - $2.05 Million	-29,664 Reduced 40.83%	42,982 $2.72 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $1.58 Million - $1.78 Million	25,597 Added 54.4%	72,646 $4.91 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $1.68 Million - $1.88 Million	-26,902 Reduced 36.38%	47,049 $3.06 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $256,931 - $335,276	4,244 Added 6.09%	73,951 $4.63 Million
Q3 2018 Nov 15, 2018	BUY	$71.28 - $78.92 $2.39 Million - $2.64 Million	33,504 Added 92.54%	69,707 $5.38 Million
Q2 2018 Aug 15, 2018	BUY	$64.88 - $75.68 $1.81 Million - $2.11 Million	27,846 Added 333.21%	36,203 $2.57 Million
Q1 2018 May 16, 2018	SELL	$72.84 - $88.8 $1.15 Million - $1.41 Million	-15,835 Reduced 65.46%	8,357 $630,000
Q4 2017 Feb 15, 2018	BUY	$71.15 - $83.52 $1.18 Million - $1.38 Million	16,548 Added 216.48%	24,192 $1.73 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $551,208 - $653,332	7,644	7,644 $619,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Account

Verition Fund Management LLC Gilead Sciences, Inc. Transaction History